Large-scale proteomic identification of S100 proteins in breast cancer tissues.
BACKGROUND
Attempts to reduce morbidity and mortality in breast cancer is based on efforts to identify novel biomarkers to support prognosis and therapeutic choices. The present study has focussed on S100 proteins as a potentially promising group of markers in cancer development and progression. One reason of interest in this family of proteins is because the majority of the S100 genes are clustered on a region of human chromosome 1q21 that is prone to genomic rearrangements. Moreover, there is increasing evidence that S100 proteins are often up-regulated in many cancers, including breast, and this is frequently associated with tumour progression.


METHODS
Samples of breast cancer tissues were obtained during surgical intervention, according to the bioethical recommendations, and cryo-preserved until used. Tissue extracts were submitted to proteomic preparations for 2D-IPG. Protein identification was performed by N-terminal sequencing and/or peptide mass finger printing.


RESULTS
The majority of the detected S100 proteins were absent, or present at very low levels, in the non-tumoral tissues adjacent to the primary tumor. This finding strengthens the role of S100 proteins as putative biomarkers. The proteomic screening of 100 cryo-preserved breast cancer tissues showed that some proteins were ubiquitously expressed in almost all patients while others appeared more sporadic. Most, if not all, of the detected S100 members appeared reciprocally correlated. Finally, from the perspective of biomarkers establishment, a promising finding was the observation that patients which developed distant metastases after a three year follow-up showed a general tendency of higher S100 protein expression, compared to the disease-free group.


CONCLUSIONS
This article reports for the first time the comparative proteomic screening of several S100 protein members among a large group of breast cancer patients. The results obtained strongly support the hypothesis that a significant deregulation of multiple S100 protein members is associated with breast cancer progression, and suggest that these proteins might act as potential prognostic factors for patient stratification. We propose that this may offer a significant contribution to the knowledge and clinical applications of the S100 protein family to breast cancer.
Cancemi
Patrizia
P
Dipartimento di Oncologia Sperimentale e Applicazioni Cliniche (DOSAC), Università di Palermo, Palermo, Italy.
Di Cara
Gianluca
G
Albanese
Nadia Ninfa
NN
Costantini
Francesca
F
Marabeti
Maria Rita
MR
Musso
Rosa
R
Lupo
Carmelo
C
Roz
Elena
E
Pucci-Minafra
Ida
I
D014408:Biomarkers, Tumor / Q000378:metabolism*; D015153:Blotting, Western; D001940:Breast / Q000378:metabolism* / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D015331:Cohort Studies; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D011379:Prognosis; D020543:Proteome / Q000032:analysis*; D009418:S100 Proteins / Q000378:metabolism*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D014408:Biomarkers, Tumor; D020543:Proteome; D009418:S100 Proteins
Am J Pathol. 2010 Feb;176(2):528-35
20019188
Anal Biochem. 1976 May 7;72:248-54
942051
Oncogene. 2005 Feb 17;24(8):1445-54
15608682
Clin Cancer Res. 2006 Sep 15;12(18):5417-22
17000675
Biochim Biophys Acta. 2009 Jun;1793(6):993-1007
19121341
Biomarkers. 2006 May-Jun;11(3):262-9
16760135
Protein Sci. 2008 Oct;17(10):1663-70
18694925
Int J Colorectal Dis. 2008 Jul;23(7):675-82
18340452
J Biol Chem. 2005 May 27;280(21):20833-41
15788416
Clin Cancer Res. 2005 Nov 1;11(21):7785-93
16278400
Int J Biochem Cell Biol. 2001 Jul;33(7):637-68
11390274
Biochem Biophys Res Commun. 2003 Jul 25;307(2):375-81
12859967
Histol Histopathol. 2007 Sep;22(9):1025-32
17523080
J Biol Chem. 2009 May 15;284(20):13804-13811
19297317
J Pathol. 2007 Nov;213(3):275-82
17940995
Biochim Biophys Acta. 1999 Jul 8;1450(3):191-231
10395934
Front Biosci. 2002 May 01;7:d1356-68
11991838
Biochem J. 2006 Jun 1;396(2):201-14
16683912
Biochem Biophys Res Commun. 1965 Jun 9;19(6):739-44
4953930
Histopathology. 2005 Mar;46(3):256-69
15720411
Ann N Y Acad Sci. 2002 Jun;963:122-39
12095937
Cancer Res. 2002 Dec 1;62(23):6823-6
12460893
Hippokratia. 2008;12(4):198-204
19158963
Int J Cancer. 2005 Aug 20;116(2):285-90
15800916
Thorax. 2008 Apr;63(4):352-9
18364444
Eur J Surg Oncol. 2008 Apr;34(4):357-64
17566693
J Cancer Res Clin Oncol. 2007 Apr;133(4):253-61
17136347
Cancer Res. 2005 Nov 15;65(22):10265-72
16288014
Cancer Res. 2005 Jul 1;65(13):5696-702
15994944
Int J Biochem Cell Biol. 2009 Apr;41(4):784-90
18765292
Microsc Res Tech. 2003 Apr 15;60(6):540-51
12645002
J Proteome Res. 2008 Apr;7(4):1412-8
18284189
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):649-54
17416753
J Dig Dis. 2007 Nov;8(4):186-93
17970874
Proteomics. 2002 Jul;2(7):919-27
12124937